Updated September 28, 2018 09:20:04When the United States Department of Health and Human Services announced that it would begin releasing data on its depression screening program in 2018, the reaction from the public was immediate and muted.

The results of the program, which had been under development since 2004, had largely been good.

According to the CDC, the program screened more than 1 million people, or about 15% of the total U.N. population, in 2015, when it was first implemented.

The U.K. and other countries had launched similar programs in the early 2000s, but by then depression had become an international epidemic.

More than 1.1 million people died from depression in 2015.

The data the United Kingdom is releasing for its depression screenings is incomplete, and it is unclear whether its results compare to other countries.

But it does offer some clues.

The United Kingdom also has a high rate of depression.

For example, the suicide rate for people aged between 15 and 44 in England is more than five times the national rate of 1.3 per 100,000, according to the most recent data available from the Office for National Statistics.

That same data also shows that more people die of depression in England than any other country.

The rate is higher in London, Scotland and Wales than in other major cities such as Paris, New York, Tokyo and Seoul.

The American Psychiatric Association has also released data on the U. S. population that compares the rates of depression among people ages 18 to 34 with the rate in adults aged 45 and older.

The report shows that in 2015 the U,S.

had the lowest rate of suicide among adults aged 15 to 44 and the highest rate of depressive disorders among people aged 45 to 64.

It also found that the U.,S.

has one of the highest rates of suicide by overdose in the world, with a suicide rate of 13.6 per 100 in 2015 among people who had attempted suicide, compared with 4.6 in Denmark, 3.7 in Switzerland and 2.5 in Sweden.

Depression is often treated with antidepressants, but there are concerns about whether these drugs can be effective.

Researchers say there is no clear consensus among experts as to whether they can be a good treatment for depression, which can cause anxiety, panic attacks, depression and suicidal thoughts.

The Department of Justice said it was developing new guidelines that would require insurers to cover the medications.

The American Psychiatric Associations said the guidelines would be “too broad” and that it had already begun exploring options for coverage.

The federal guidelines were expected to be released in 2018.

The U. k. and the U the U is also working to develop a plan for how to pay for depression treatment.